Cargando…
Inhibition of IDH3α Enhanced the Efficacy of Chemoimmunotherapy by Regulating Acidic Tumor Microenvironments
SIMPLE SUMMARY: Isocitrate dehydrogenase 3α (IDH3α) is highly expressed in many cancers and is associated with poor patient prognosis. However, it is not clear whether the aberrant expression of IDH3α is related to the efficacy of chemoimmunotherapy against cancer. We used in vivo and in vitro exper...
Autores principales: | Zhang, Lingling, Song, Yang, Dai, Xiaoyan, Xu, Wenwen, Li, Mengxia, Zhu, Yuxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046804/ https://www.ncbi.nlm.nih.gov/pubmed/36980689 http://dx.doi.org/10.3390/cancers15061802 |
Ejemplares similares
-
Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment
por: Gu, Jun, et al.
Publicado: (2022) -
MAPK signaling regulates the efficacy of chemoimmunotherapy
por: Ghiringhelli, François
Publicado: (2022) -
Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in non–small‐cell lung cancer
por: Han, Rui, et al.
Publicado: (2023) -
The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells
por: Kuczma, Michal P., et al.
Publicado: (2017) -
MEK inhibition invigorates chemoimmunotherapy by tumor mitophagy-induced CXCL10 expression
por: Rodriguez, B. Leticia, et al.
Publicado: (2022)